Scholars Central

ArticlePublished 2016

Is procalcitonin correctly used in medical and surgical departments only in cases with severe bacterial infections? Correlations with the severity scores used in the ICU.

Authors: Victoria Birlutiu, Rare Mircea Birlutiu

Biomedical Research

Volume 27 · Issue 1

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

The use of procalcitonin (PCT) in the diagnosis of severe bacterial infections has been tested and proven by numerous international studies. We intend to evaluate how PCT is used in patient admission in various medical and surgical departments and the correlations between PCT and severity scores used for patients in critical state. The death rate correlated with the PCT values above 10 ng/ml and thrombocytopenia, APACHE II score and with a mean SOFA score of 8. For a cutoff value of 0.5 ng/ml in our study the sensitivity of the PCT was 86% with 91% specificity. Placing PCT in a key step in the schemes of the management of patients suspected of sepsis is an important factor in determining the strategy that should be followed, the antibacterial and immunological therapy and the treatment costs implication. Procalcitonin remains so far the best pro-inflammatory marker used in the management of patients with severe bacterial infections.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Biomedical Research.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalBiomedical Research
  • SubjectPathology & Lab Medicine
  • BylineArticles whose byline prints “Victoria Birlutiu”
  • BylineArticles whose byline prints “Rare Mircea Birlutiu”